Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Immunological Reviews|April 21, 2006
A library of gene expression signatures to illuminate normal and pathological lymphoid biologyArthur L Shaffer, George Wright, Liming Yang, et al.
Comparative Medicine|November 18, 2014
Papiine herpesvirus 2 as a predictive model for drug sensitivity of Macacine herpesvirus 1 (monkey B virus)Lauren A Brush, Darla H Black, Kimberly A Mccormack, et al.
The Journal of Biological Chemistry|November 19, 2002
Analysis of gamma c-family cytokine target genes. Identification of dual-specificity phosphatase 5 (DUSP5) as a regulator of mitogen-activated protein kinase activity in interleukin-2 signalingPanu E Kovanen, Andreas Rosenwald, Jacqueline Fu, et al.
JAMA Network Open|November 30, 2023
Transitional Care Interventions From Hospital to Community to Reduce Health Care Use and Improve Patient Outcomes: A Systematic Review and Network Meta-AnalysisNatasha Tyler, Alexander Hodkinson, Claire Planner, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 24, 2008
Compensatory IKKalpha activation of classical NF-kappaB signaling during IKKbeta inhibition identified by an RNA interference sensitization screenLloyd T Lam, R Eric Davis, Vu N Ngo, et al.
Blood|December 28, 2007
Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphomaLloyd T Lam, George Wright, R Eric Davis, et al.
Journal of Spine Surgery (Hong Kong)|June 15, 2026
Real-world outcomes of minimally invasive posterior thoracic and lumbar spine fusion surgery versus open surgery in the Finnish Spine RegistryJukka Huttunen, Pietari Kinnunen, Nikolai Klimko, et al.
Blood|February 19, 2005
B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasisKieron Dunleavy, Frances Hakim, Hyun Kyung Kim, et al.
Blood|April 22, 2009
Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphomaKieron Dunleavy, Stefania Pittaluga, Myron S Czuczman, et al.
Leukemia & Lymphoma|April 15, 2021
Phase 1b/2 study of ibrutinib and lenalidomide with dose-adjusted EPOCH-R in patients with relapsed/refractory diffuse large B-cell lymphomaWyndham H Wilson, Tycel Phillips, Leslie Popplewell, et al.
Pageof 8